These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 33937363)
1. A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease. Morrow GB; Whyte CS; Mutch NJ Front Cardiovasc Med; 2021; 8():653655. PubMed ID: 33937363 [TBL] [Abstract][Full Text] [Related]
2. Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis. Urano T; Suzuki Y; Iwaki T; Sano H; Honkura N; Castellino FJ Curr Drug Targets; 2019; 20(16):1695-1701. PubMed ID: 31309890 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of PAI-1: a new anti-thrombotic approach. Wu Q; Zhao Z Curr Drug Targets Cardiovasc Haematol Disord; 2002 Jun; 2(1):27-42. PubMed ID: 12769655 [TBL] [Abstract][Full Text] [Related]
5. Fibrinolysis: the key to new pathogenetic mechanisms. Zorio E; Gilabert-Estellés J; España F; Ramón LA; Cosín R; Estellés A Curr Med Chem; 2008; 15(9):923-9. PubMed ID: 18473800 [TBL] [Abstract][Full Text] [Related]
6. PAI-1, progress in understanding the clinical problem and its aetiology. Iwaki T; Urano T; Umemura K Br J Haematol; 2012 May; 157(3):291-8. PubMed ID: 22360729 [TBL] [Abstract][Full Text] [Related]
7. Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop. Qureshi T; Goswami S; McClintock CS; Ramsey MT; Peterson CB Protein Sci; 2016 Feb; 25(2):499-510. PubMed ID: 26548921 [TBL] [Abstract][Full Text] [Related]
8. Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition. Sillen M; Declerck PJ Front Cardiovasc Med; 2020; 7():622473. PubMed ID: 33415130 [TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment. Gramling MW; Church FC Thromb Res; 2010 May; 125(5):377-81. PubMed ID: 20079523 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of PAI-1 antiproteolytic activity against tPA by RNA aptamers. Damare J; Brandal S; Fortenberry YM Nucleic Acid Ther; 2014 Aug; 24(4):239-49. PubMed ID: 24922319 [TBL] [Abstract][Full Text] [Related]
12. Clinical implications of elevated PAI-1 revisited: multiple arterial thrombosis in a patient with essential thrombocythemia and elevated plasminogen activator inhibitor-1 (PAI-1) levels: a case report and review of the literature. Senno SL; Pechet L J Thromb Thrombolysis; 1999 Aug; 8(2):105-12. PubMed ID: 10436140 [TBL] [Abstract][Full Text] [Related]
13. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression. Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076 [TBL] [Abstract][Full Text] [Related]
14. Serpin regulation of fibrinolytic system: implications for therapeutic applications in cardiovascular diseases. Al-Horani RA Cardiovasc Hematol Agents Med Chem; 2014; 12(2):91-125. PubMed ID: 25374013 [TBL] [Abstract][Full Text] [Related]
15. Crystal Structure of the Michaelis Complex between Tissue-type Plasminogen Activator and Plasminogen Activators Inhibitor-1. Gong L; Liu M; Zeng T; Shi X; Yuan C; Andreasen PA; Huang M J Biol Chem; 2015 Oct; 290(43):25795-804. PubMed ID: 26324706 [TBL] [Abstract][Full Text] [Related]
16. Small molecules inhibitors of plasminogen activator inhibitor-1 - an overview. Rouch A; Vanucci-Bacqué C; Bedos-Belval F; Baltas M Eur J Med Chem; 2015 Mar; 92():619-36. PubMed ID: 25615797 [TBL] [Abstract][Full Text] [Related]
17. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1. Skurk T; Hauner H Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1357-64. PubMed ID: 15356668 [TBL] [Abstract][Full Text] [Related]
18. Recombinant plasminogen activator inhibitor type 1: a review of structural, functional, and biological aspects. Reilly TM; Mousa SA; Seetharam R; Racanelli AL Blood Coagul Fibrinolysis; 1994 Feb; 5(1):73-81. PubMed ID: 8180342 [TBL] [Abstract][Full Text] [Related]
19. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition. Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427 [TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor-1 potentiates LPS-induced neutrophil activation through a JNK-mediated pathway. Kwak SH; Wang XQ; He Q; Fang WF; Mitra S; Bdeir K; Ploplis VA; Xu Z; Idell S; Cines D; Abraham E Thromb Haemost; 2006 May; 95(5):829-35. PubMed ID: 16676075 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]